Literature DB >> 9586749

Visual acuity repeatability in keratoconus: impact on sample size. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group.

M O Gordon1, K B Schechtman, L J Davis, T T McMahon, J Schornack, K Zadnik.   

Abstract

PURPOSE: The purpose of this paper is to determine the repeatability of visual acuity measurement in keratoconus and to describe the impact of measurement repeatability on sample size.
METHODS: Approximately 10% of a 1209 patient sample in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study were selected randomly for a Repeat CLEK Study Visit. Patients were tested at the 15 CLEK Participating Clinics. The test-retest sample consisted of 1 34 keratoconus patients who met the entry criteria of the CLEK Study. High and low contrast Bailey-Lovie visual acuity was measured with the patient's habitual visual correction (entrance visual acuity monocularly and binocularly), and with the best correction monocularly (either the patient's rigid contact lens and over-refraction, or with a CLEK Study trial lens and appropriate over-refraction) at two visits separated by a median of 90 days (range 22 to 268 days).
RESULTS: The mean absolute differences between the number of letters correct at the two visits ranged from a low of 3.24 +/- 3.1 for entrance high contrast binocular acuity to a high of 5.48 +/- 5.1 for best corrected low contrast monocular acuity. Intraclass correlation coefficients ranged from 0.757 to 0.853. The visual acuity score was somewhat higher at the Repeat Visit than at the Baseline Visit when the examiners were different between visits.
CONCLUSIONS: Given the variable vision reported by keratoconus patients, visual acuity in this sample was very repeatable. Repeatability was slightly poorer when different examiners tested visual acuity at the Baseline and Repeat Visits.

Entities:  

Mesh:

Year:  1998        PMID: 9586749     DOI: 10.1097/00006324-199804000-00021

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  9 in total

1.  The relation between disease asymmetry and severity in keratoconus.

Authors:  J J Nichols; K Steger-May; T B Edrington; K Zadnik
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

2.  Contrast and glare testing in keratoconus and after penetrating keratoplasty.

Authors:  K Pesudovs; P Schoneveld; R J Seto; D J Coster
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

3.  Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date.

Authors:  H Wagner; J T Barr; K Zadnik
Journal:  Cont Lens Anterior Eye       Date:  2007-05-03       Impact factor: 3.077

4.  Mesopic visual acuity is less crowded.

Authors:  František Pluháček; John Siderov
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-05-28       Impact factor: 3.117

5.  Asymmetry in keratoconus and vision-related quality of life.

Authors:  Lisa A Jones-Jordan; Jeffrey J Walline; Loraine T Sinnott; Steven M Kymes; Karla Zadnik
Journal:  Cornea       Date:  2013-03       Impact factor: 2.651

6.  The Study of Progression of Adult Nearsightedness (SPAN): design and baseline characteristics.

Authors:  Mark A Bullimore; Kathleen S Reuter; Lisa A Jones; G Lynn Mitchell; Jessica Zoz; Marjorie J Rah
Journal:  Optom Vis Sci       Date:  2006-08       Impact factor: 1.973

7.  The Effects of Center-near and Center-distance Multifocal Contact Lenses on Peripheral Defocus and Visual Acuity.

Authors:  Lea A Hair; Elaine M Steffensen; David A Berntsen
Journal:  Optom Vis Sci       Date:  2021-08-01       Impact factor: 2.106

8.  Changes in the quality-of-life of people with keratoconus.

Authors:  Steven M Kymes; Jeffrey J Walline; Karla Zadnik; John Sterling; Mae O Gordon
Journal:  Am J Ophthalmol       Date:  2008-01-28       Impact factor: 5.258

9.  Repeatability of Aberrometry-Based Automated Subjective Refraction in Healthy and Keratoconus Subjects.

Authors:  Gonzalo Carracedo; Carlos Carpena-Torres; Cristina Pastrana; Ana Privado-Aroco; María Serramito; Laura Batres
Journal:  J Ophthalmol       Date:  2020-10-30       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.